Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

Back to Top

4th International Conference on Capacity - Controversies and the Cutting Edge

The 4th International Capacity Conference held in conjunction with Capacity Australia promises to deliver as novel and engaging programme as ever. A range of speakers from six countries will address small and big decision-making, from capacity to lead a country, to capacity to ride a mobility scooter. We will also be showcasing a number of education initiatives that are spreading the word to educate clinicians and the community about capacity, the law and human rights. Interest in the field of capacity has burgeoned since IPA established the Testamentary Capacity Taskforce in 2008, and broadened it to the Capacity Shared Interest forum in 2011, and this 4th Conference is testimony to this.

(download the one-sheet PDF here.)

Prof Robin Jacoby: Capacity to be president or prime minister
Prof Helen Chiu: Fluctuating capacity
Alison Douglass, Barrister;
Dr Greg Young;
Prof John McMillan::
The New Zealand Capacity Toolkit
Prof Carmelle Peisah: The global capacity education tool
Karen Reimers, MD, FRCPC: Practical Tips for Geriatric Forensic Evaluations
Prof Carmelle Peisah: Special Session on Capacity and Research Trials *
Dr Jane Casey: Capacity and internet scamming
Dr Anne Wand: Family conflict, undue influence and suicide: a case study
Dr Millie Ho: Capacity beyond driving: operating non-regulated vehicles
Dr Tiffany Jessop: Empowering community members about capacity and human rights
Prof Jin Narumoto &
Prof Nahoko Kusaka:
Communication robots and capacity

* This special session on Capacity and Research Trials will have relevance to all clinical researchers. Clinical research with cognitively impaired adults is essential for improving the treatment of many conditions that serve the benefits of that very population. Cognitively impaired adults have an equitable right to research being conducted in areas relevant to their treatment and care, and they should not be denied the opportunity and autonomy of choice to participate, or not participate, in such research. This session will address some of the principles of research governance designed to safeguard the interests of adults with impaired capacity, as well as providing guidelines as to the assessment of capacity to consent to research, supported decision-making in this context, and strategies to deal with the dynamic nature of capacity. Some of the ethical and practical dilemmas of how and when to withdraw from research or stop treatment, despite earlier consent or assent, including the dilemma of what to do when someone has “changed their mind when their mind has changed." The session will have dual components of a didactic presentation and "audience as experts" to address these internationally relevant, and complex issues.


Acadia Pharmaceuticals Axsome Cambridge University Press Cerevel Lundbeck Otsuka